Ellevest Inc’s Syndax Pharmaceuticals SNDX Stock Holding History

Ellevest Inc’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-84	Closed	-$1K	–	1274
2019 Q4	$1K	Buy	+84	New	+$617	﹤0.01%	860

Other funds holding SNDX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Ellevest Inc's SNDX Position: Q1 2020 in Review

Ellevest Inc sold out of Syndax Pharmaceuticals (SNDX) in Q1 2020, closing a stake of 84 shares — an estimated $1K sold.

Ellevest Inc first reported a position in SNDX in Q4 2019 and held it in 1 quarter. The position peaked at $1K in Q4 2019. 83 funds tracked by Wall St. Rank hold SNDX as of Q1 2020.

Ellevest Inc reported no remaining Syndax Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Ellevest Inc sold 84 Syndax Pharmaceuticals shares in Q1 2020, an estimated $1K.
Ellevest Inc first reported a position in Syndax Pharmaceuticals in Q4 2019 and held it in 1 quarter.
Ellevest Inc's Syndax Pharmaceuticals position peaked at $1K in Q4 2019.
83 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2020.

Based on Ellevest Inc's 13F filing for Q1 2020, filed 13 Apr 2020.